{"id":732880,"date":"2023-02-21T07:09:14","date_gmt":"2023-02-21T12:09:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/"},"modified":"2023-02-21T07:09:14","modified_gmt":"2023-02-21T12:09:14","slug":"cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/","title":{"rendered":"Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023"},"content":{"rendered":"
\n

STAMFORD, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc.\u00a0(Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a conference call and live audio webcast on Monday, March 6, 2023, at 4:30 p.m. EST to report fourth quarter and full year 2022 financial results and provide a corporate update.<\/p>\n

To participate in the conference call, please register here<\/a>. Registrants will receive the dial-in numbers and a unique PIN.<\/p>\n

A live audio webcast and archived replay of the call will be available under \u201cEvents & Presentations\u201d in the News & Investors section of the Company\u2019s website at www.CaraTherapeutics.com<\/a>.<\/p>\n

\n About Cara Therapeutics<\/strong>\n <\/p>\n

Cara Therapeutics is a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company\u2019s KORSUVA\u00ae (difelikefalin) injection is the first and only FDA-approved treatment for moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis. The Company is developing an oral formulation of difelikefalin and has initiated Phase 3 programs for the treatment of pruritus in patients with non-dialysis dependent advanced chronic kidney disease and atopic dermatitis. The Company has completed a Phase 2 proof-of-concept trial of oral difelikefalin for the treatment of moderate-to-severe pruritus in patients with notalgia paresthetica and plans to initiate a Phase 2\/3 clinical trial program in the first quarter of 2023. For more information, visit www.CaraTherapeutics.com<\/u><\/a> and follow the company on Twitter<\/u><\/a>, LinkedIn<\/u><\/a> and Instagram<\/u><\/a>.<\/p>\n

\n MEDIA CONTACT:<\/strong>
\n
Annie Spinetta
6 Degrees
973-768-2170
aspinetta@6degreespr.com<\/a><\/p>\n

\n INVESTOR CONTACT:<\/strong>
\n
Iris Francesconi, Ph.D.
Cara Therapeutics
203-406-3700
investor@caratherapeutics.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

STAMFORD, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc.\u00a0(Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a conference call and live audio webcast on Monday, March 6, 2023, at 4:30 p.m. EST to report fourth quarter and full year 2022 financial results and provide a corporate update. To participate in the conference call, please register here. Registrants will receive the dial-in numbers and a unique PIN. A live audio webcast and archived replay of the call will be available under \u201cEvents & Presentations\u201d in the News & Investors section of the Company\u2019s website at www.CaraTherapeutics.com. About Cara Therapeutics Cara Therapeutics … <\/p>\n

Continue reading “Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-732880","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"STAMFORD, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc.\u00a0(Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a conference call and live audio webcast on Monday, March 6, 2023, at 4:30 p.m. EST to report fourth quarter and full year 2022 financial results and provide a corporate update. To participate in the conference call, please register here. Registrants will receive the dial-in numbers and a unique PIN. A live audio webcast and archived replay of the call will be available under \u201cEvents & Presentations\u201d in the News & Investors section of the Company\u2019s website at www.CaraTherapeutics.com. About Cara Therapeutics Cara Therapeutics … Continue reading "Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-21T12:09:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MjA5OSM1NDE3MjQ1IzIwMDYwMzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023\",\"datePublished\":\"2023-02-21T12:09:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\\\/\"},\"wordCount\":282,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1MjA5OSM1NDE3MjQ1IzIwMDYwMzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\\\/\",\"name\":\"Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1MjA5OSM1NDE3MjQ1IzIwMDYwMzk=\",\"datePublished\":\"2023-02-21T12:09:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1MjA5OSM1NDE3MjQ1IzIwMDYwMzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1MjA5OSM1NDE3MjQ1IzIwMDYwMzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/","og_locale":"en_US","og_type":"article","og_title":"Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 - Market Newsdesk","og_description":"STAMFORD, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc.\u00a0(Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a conference call and live audio webcast on Monday, March 6, 2023, at 4:30 p.m. EST to report fourth quarter and full year 2022 financial results and provide a corporate update. To participate in the conference call, please register here. Registrants will receive the dial-in numbers and a unique PIN. A live audio webcast and archived replay of the call will be available under \u201cEvents & Presentations\u201d in the News & Investors section of the Company\u2019s website at www.CaraTherapeutics.com. About Cara Therapeutics Cara Therapeutics … Continue reading \"Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-21T12:09:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MjA5OSM1NDE3MjQ1IzIwMDYwMzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023","datePublished":"2023-02-21T12:09:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/"},"wordCount":282,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MjA5OSM1NDE3MjQ1IzIwMDYwMzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/","name":"Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MjA5OSM1NDE3MjQ1IzIwMDYwMzk=","datePublished":"2023-02-21T12:09:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MjA5OSM1NDE3MjQ1IzIwMDYwMzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MjA5OSM1NDE3MjQ1IzIwMDYwMzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cara-therapeutics-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-6-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/732880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=732880"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/732880\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=732880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=732880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=732880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}